The role of bevacizumab in combination with pegylated liposomal doxorubicin in patients with platinum-resistant recurrent or refractory ovarian cancers.

被引：0
|
作者：
Kouta, H.
Kudoh, K.
Takano, M.
Kikuchi, R.
Kita, T.
Goto, T.
Furuya, K.
Kikuchi, Y.
机构：
[1] Ohki Mem Canc Ctr Women, Tokorozawa, Saitama, Japan
[2] Nishisaitama Chuo Natl Hosp, Tokorozawa, Saitama, Japan
[3] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan
[4] Nara Prefectural Nara Hosp, Nara, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5018
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers
    Kudoh, Kazuya
    Takano, Masashi
    Kouta, Hiroko
    Kikuchi, Ryoko
    Kita, Tsunekazu
    Miyamoto, Morikazu
    Watanabe, Akio
    Kato, Masafumi
    Goto, Tomoko
    Kikuchi, Yoshihiro
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 233 - 237
  • [2] Pembrolizumab in combination with bevacizumab and pegylated liposomal doxorubicin in patients with platinum-resistant epithelial ovarian cancer.
    Michels, Judith
    Ghiringhelli, Francois
    Frenel, Jean-Sebastien
    Brard, Caroline
    You, Benoit
    Floquet, Anne
    Eberst, Lauriane
    Bahleda, Rastilav
    Genestie, Catherine
    Balleyguier, Corinne
    Broutin, Sophie
    Pautier, Patricia
    Colomba, Emeline
    Pommeret, Fanny
    Massard, Christophe
    Marabelle, Aurelien
    Leary, Alexandra
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] The outcome of patients with platinum-resistant/refractory ovarian cancer treated with the combination of pegylated liposomal doxorubicin and gemcitabine
    Galic, V.
    Boulay, R.
    Thomas, M.
    Miller, R.
    Gillenwater, C.
    Chen, C.
    Martino, M.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S48 - S48
  • [4] Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer
    Karaoglu, Aziz
    Arslan, Ulku Yalcintas
    Ozkan, Metin
    Kalender, Mehmet Emin
    Alici, Suleyman
    Coskun, Ugur
    Gumus, Mahmut
    Celenkoglu, Gokhan
    Er, Ozlem
    Sevinc, Alper
    Buyukberber, Suleyman
    Alkis, Necati
    Benekli, Mustafa
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (01) : 63 - 66
  • [5] Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results
    Czok, S.
    Jewell, A.
    Shawki, S.
    Boyd, L.
    Smith, H.
    Blank, S.
    Muller, C.
    Verschraegen, C.
    Muggia, F.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S83 - S83
  • [6] Real-world effectiveness of pegylated liposomal doxorubicin versus gemcitabine in platinum-resistant/refractory recurrent ovarian cancer
    Charakorn, Chuenkamon
    Manchana, Tarinee
    Siriyotha, Sukanya
    Thakkinstian, Ammarin
    Chittithaworn, Suwicha
    Oranratanaphan, Shina
    Lekskul, Navamol
    Paiwattananupant, Krissada
    Phoolcharoen, Natacha
    Panyavaranant, Pinyada
    Promwattanaphan, Lukkana
    Areeruk, Wilasinee
    Kongsawatvorakul, Chompunoot
    Satitniramai, Sikarn
    Mathaveechotikul, Panida Panida
    Lertkhachonsuk, Arb-Aroon
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A196 - A196
  • [7] Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer
    Verhaar-Langereis, M
    Karakus, A
    Van Eijkeren, M
    Voest, E
    Witteveen, E
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (01) : 65 - 70
  • [8] Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer
    Mo, Dun-Chang
    Ren, Tao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (05) : 522 - +
  • [9] Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer
    Vergote, Ignace
    Finkler, Neil J.
    Hall, James B.
    Melnyk, Ostap
    Edwards, Robert P.
    Jones, Marsha
    Keck, James G.
    Meng, Lisa
    Brown, Gail L.
    Rankin, Elaine M.
    Burke, James J.
    Boccia, Ralph V.
    Runowicz, Carolyn D.
    Rose, Peter G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 772 - 780
  • [10] Combination therapy with Bevacizumab and GEMOX for patients with platinum-resistant recurrent ovarian cancers: A phase ll study
    Takano, M.
    Ikeda, Y.
    Oda, K.
    Kouta, H.
    Kudoh, K.
    Kita, T.
    Sasaki, N.
    Goto, T.
    Furuya, K.
    Kikuchi, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S730 - S730
12345